NEUMORA THERAPEUTICS INC (NMRA) — insider trading
Health Care · NASDAQ
NEUMORA THERAPEUTICS INC (NMRA) has 60 reported SEC Form 4 insider transactions in our data, including 15 open-market sales among the most recent 60 (latest 2026-08-21).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 21,055 | — | $0 | Form 4 |
| 2026-08-21 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 20,553 | — | $0 | Form 4 |
| 2026-08-21 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 21,055 | $1.60 | $33.6K | Form 4 |
| 2026-08-21 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 21,055 | $0.72 | $15.2K | Form 4 |
| 2026-08-21 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 20,553 | $1.59 | $32.8K | Form 4 |
| 2026-08-21 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 20,553 | $0.72 | $14.8K | Form 4 |
| 2026-08-20 | Pinto Joshua | Director, Officer (President & CEO) | Grant / award / vesting (derivative) | 500,000 | — | $0 | Form 4 |
| 2026-08-20 | Milligan Michael Lee | Officer (See Remarks) | Grant / award / vesting (derivative) | 175,000 | — | $0 | Form 4 |
| 2026-08-20 | Duncan Jason | Officer (See Remarks) | Grant / award / vesting (derivative) | 375,000 | — | $0 | Form 4 |
| 2026-08-20 | BERNS PAUL L | Director, Officer (See Remarks) | Grant / award / vesting (derivative) | 500,000 | — | $0 | Form 4 |
| 2026-08-20 | Aurora Daljit Singh | Officer (See Remarks) | Grant / award / vesting (derivative) | 200,000 | — | $0 | Form 4 |
| 2026-08-20 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 21,685 | — | $0 | Form 4 |
| 2026-08-20 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 45,026 | — | $0 | Form 4 |
| 2026-08-20 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 67,741 | — | $0 | Form 4 |
| 2026-08-20 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 66,711 | $1.51 | $101.0K | Form 4 |
| 2026-08-20 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 45,026 | $0.72 | $32.4K | Form 4 |
| 2026-08-20 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 21,685 | $0.72 | $15.6K | Form 4 |
| 2026-08-20 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 67,741 | $1.51 | $102.6K | Form 4 |
| 2026-08-20 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 67,741 | $0.72 | $48.8K | Form 4 |
| 2026-08-19 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 30,918 | — | $0 | Form 4 |
| 2026-08-19 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 17,732 | — | $0 | Form 4 |
| 2026-08-19 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 13,268 | — | $0 | Form 4 |
| 2026-08-19 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 30,918 | $1.65 | $50.9K | Form 4 |
| 2026-08-19 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 30,918 | $0.72 | $22.3K | Form 4 |
| 2026-08-19 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 31,000 | $1.65 | $51.0K | Form 4 |
| 2026-08-19 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 17,732 | $0.72 | $12.8K | Form 4 |
| 2026-08-19 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 13,268 | $0.72 | $9.6K | Form 4 |
| 2026-08-18 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 34,987 | — | $0 | Form 4 |
| 2026-08-18 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 34,162 | — | $0 | Form 4 |
| 2026-08-18 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 34,987 | $1.59 | $55.5K | Form 4 |
| 2026-08-18 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 34,987 | $0.72 | $25.2K | Form 4 |
| 2026-08-18 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 34,162 | $1.58 | $54.1K | Form 4 |
| 2026-08-18 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 34,162 | $0.72 | $24.6K | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 29,737 | — | $0 | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 25,279 | — | $0 | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 1 | — | $0 | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 1,424 | — | $0 | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 15,355 | — | $0 | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion (derivative) | 40,890 | — | $0 | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 55,016 | $1.50 | $82.8K | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 29,737 | $0.72 | $21.4K | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 25,279 | $0.72 | $18.2K | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 34,020 | $1.49 | $50.5K | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 57,670 | $1.51 | $86.8K | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 1 | $0.72 | $1 | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 1,424 | $0.72 | $1.0K | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 15,355 | $0.72 | $11.1K | Form 4 |
| 2026-08-17 | Aurora Daljit Singh | Officer (See Remarks) | Option exercise / conversion | 40,890 | $0.72 | $29.4K | Form 4 |
| 2026-05-27 | Ho Maykin | Director | Grant / award / vesting (derivative) | 80,000 | — | $0 | Form 4 |
| 2026-05-27 | Halawa Alaa | Director | Grant / award / vesting (derivative) | 80,000 | — | $0 | Form 4 |
| 2026-05-27 | Piacquad David | Director | Grant / award / vesting (derivative) | 80,000 | — | $0 | Form 4 |
| 2026-05-27 | Fust Matthew K | Director | Grant / award / vesting (derivative) | 80,000 | — | $0 | Form 4 |
| 2026-05-27 | Burow Kristina | Director, 10% owner | Grant / award / vesting (derivative) | 80,000 | — | $0 | Form 4 |
| 2026-02-17 | Milligan Michael Lee | Officer (See Remarks) | Open-market sale | 1,436 | $3.57 | $5.1K | Form 4 |
| 2026-02-17 | BERNS PAUL L | Director, Officer (See Remarks) | Open-market sale | 9,819 | $3.51 | $34.5K | Form 4 |
| 2026-02-17 | Pinto Joshua | Officer (President) | Open-market sale | 5,967 | $3.54 | $21.1K | Form 4 |
| 2026-02-17 | Aurora Daljit Singh | Officer (See Remarks) | Open-market sale | 6,165 | $3.56 | $21.9K | Form 4 |
| 2026-01-08 | Duncan Jason | Officer (See Remarks) | Grant / award / vesting (derivative) | 750,000 | — | $0 | Form 4 |
| 2026-01-08 | Aurora Daljit Singh | Officer (See Remarks) | Grant / award / vesting (derivative) | 750,000 | — | $0 | Form 4 |
| 2026-01-08 | Milligan Michael Lee | Officer (See Remarks) | Grant / award / vesting (derivative) | 350,000 | — | $0 | Form 4 |
Ask the chat about NMRA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: NEUMORA THERAPEUTICS INC (NMRA).
Last updated 2026-08-21 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.